Issue 4/2010
Content (6 Articles)
A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment
Jean-Eric Tarride, Robert Hopkins, Gord Blackhouse, James M. Bowen, Matthias Bischof, Camilla Von Keyserlingk, Daria O’Reilly, Feng Xie, Ron Goeree
Cost Effectiveness of Respiratory Syncytial Virus Prophylaxis
William A. Prescott Jr, Fred Doloresco, Jack Brown, Joseph A. Paladino
Does the Funding Source Influence the Results in Economic Evaluations?
Rachael L. Fleurence, D. Eldon Spackman, Christopher Hollenbeak
Pharmacoeconomic Evaluation in Ireland
Lesley Tilson, Aisling O’Leary, Cara Usher, Michael Barry
Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis
Jeroen P. Jansen, Sabine Gaugris, Ernest H. Choy, Andrew Ostor, Julian T. Nash, Wiro Stam